investors

PRESS RELEASES

Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Angion Initiates Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Angion Announces Key Addition to Management Team and Appointments to Board of Directors
Angion to Present Results from Multiple Preclinical and Health Economic Studies at the American Transplant Congress Virtual Meeting
see more

EVENTS

J.P. Morgan Healthcare Conference
see more

CORPORATE PRESENTATIONS